Drug profile · INN
gusperimus
SPANIDIN
gusperimus (SPANIDIN) is an FDA-listed pharmaceutical active ingredient.
EMA: application withdrawn
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — gusperimus
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
gusperimus (SPANIDIN) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN gusperimus
Brand SPANIDIN
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Frequently asked questions
What is gusperimus?
gusperimus (SPANIDIN) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for gusperimus?
SPANIDIN is a marketed brand name for gusperimus. Check FDA Drugs@FDA for the current US label holder and prescribing information.